Under the auspices of the Tanaka Project of the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program), an open seminar was held on October 26 to introduce leading-edge cancer research with the aim of promoting research exchange and accelerating new research.
On that day, 90 people participated, and 4 researchers representing the United States and Japan introduced leading-edge research on cancer-related genes and proteins. In addition, core researcher Koichi Tanaka presented a brief overview of the research project.
|
Seminar Program
|
|
| 14:00-14:20 | About the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) （906KB） Koichi Tanaka, General Manager (Koichi Tanaka Laboratory of Advanced Science and Technology, Shimadzu Corporation) |
| 14:20-14:50 | Genomic analysis of human lung cancers Prof. Matthew Meyerson (Dana-Farber Cancer Institute) |
| 14:50-15:20 | Patient-derived Tumor Explants for the Development of Proteogenomic Maps of Breast Cancer Prof. Matthew James Ellis (Washington University) |
| 15:20-15:50 | Genetics and Genomics of Colorectal Cancer Prof. Raju Kucherlapati (Harvard University) |
| 16:00-16:30 | Antibody Development for Diagnosis and Treatment of Cancer and Intractable Diseases Prof. Takao Hamakubo (Research Center for Advanced Science and Technology, The University of Tokyo) |
| Related pamphlet （192KB） | |
